講演情報
[O8-02]デング熱ワクチン開発での抗体依存性感染増強（ADE）の評価
Antibody-Dependent Enhancement in Dengue Vaccine Evaluations: Key Insights
*Kouichi Morita1,2, Dengue Vaccine Development Group2 (1. Nagasaki University, Dejima Infectious Disease Research Alliance (DIDA) (Japan), 2. Nagasaki University, Vaccine Research and Development Center (VRDC) (Japan))
